Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Stuttgart - Delayed Quote EUR

Grifols SA (OZTA.SG)

Compare
10.43
+0.03
+(0.29%)
At close: February 28 at 12:11:27 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,006,119
6,591,977
6,063,967
4,933,118
5,340,038
Cost of Revenue
4,275,268
4,097,406
3,832,437
2,970,522
3,084,873
Gross Profit
2,730,851
2,494,571
2,231,530
1,962,596
2,255,165
Operating Expense
1,714,014
1,758,913
1,529,328
1,400,087
1,279,832
Operating Income
1,016,837
735,658
702,202
562,509
975,333
Net Non Operating Interest Income Expense
-696,186
-534,538
-444,464
-256,151
-241,618
Other Income Expense
35,737
22,898
103,519
44,095
144,914
Pretax Income
356,388
224,018
361,257
350,453
878,629
Tax Provision
132,086
43,349
90,111
85,126
169,639
Net Income Common Stockholders
161,491
59,315
208,279
188,726
618,546
Diluted NI Available to Com Stockholders
161,491
59,315
208,279
188,726
618,546
Basic EPS
0.24
0.09
0.31
0.27
0.90
Diluted EPS
0.24
0.09
0.31
0.27
0.90
Basic Average Shares
679,629.20
679,756.29
679,805.14
681,556.94
685,515.74
Diluted Average Shares
679,629.20
679,756.29
679,805.14
681,556.94
685,515.74
Total Operating Income as Reported
1,092,489
799,398
805,680
595,064
996,132
Total Expenses
5,989,282
5,856,319
5,361,765
4,370,609
4,364,705
Net Income from Continuing & Discontinued Operation
161,491
59,315
208,279
188,726
618,546
Normalized Income
186,615.68
91,490.52
207,135.23
205,113.54
566,939.16
Interest Income
--
62,326
33,859
11,551
8,021
Interest Expense
677,708
516,060
444,543
233,813
222,921
Net Interest Income
-696,186
-534,538
-444,464
-256,151
-241,618
EBIT
1,034,096
740,078
805,800
584,266
1,101,550
EBITDA
1,467,068
1,181,996
1,213,664
944,033
1,423,083
Reconciled Cost of Revenue
4,275,268
3,762,627
3,512,630
2,703,535
3,084,873
Reconciled Depreciation
432,972
441,918
407,864
359,767
321,533
Net Income from Continuing Operation Net Minority Interest
161,491
59,315
208,279
188,726
618,546
Total Unusual Items Excluding Goodwill
-39,920
-39,920
1,523
-21,648
63,949
Total Unusual Items
-39,920
-39,920
1,523
-21,648
63,949
Normalized EBITDA
1,506,988
1,221,916
1,212,141
965,681
1,359,134
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,795.32
-7,744.48
379.23
-5,260.46
12,342.16
12/31/2020 - 4/2/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BRM.MU Bristol-Myers Squibb Co
56.83
+3.29%
 
ABBV34.SA AbbVie Inc.
76.22
+2.32%
 
YPHA.F Astellas Pharma Inc.
9.05
-1.09%
 
1643.HK MODERN CHI MED
0.390
-1.27%
 
BRM.F Bristol-Myers Squibb Company
55.92
-0.85%
 
COPNz.XC
 
NOVNEE.SW Novartis AG
98.06
+0.40%
 
YPH.BE Astellas Pharma Inc
9.29
-2.01%
 
BAYN.SG Bayer AG
22.66
+0.22%
 
MRK.BA Merck & Co., Inc.
22,375.00
+1.94%